| Financial Year |
March 31 2023 |
| Monetary Funds |
3,437,959,444.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
36,360,532.00 |
| Accounts Receivable |
3,720,018,074.38 |
| Advances to Suppliers |
289,254,503.29 |
| Other Receivables |
51,419,225.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,588,069,462.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
83,892,674.75 |
| Total Current Assets |
10,474,151,909.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
650,321,895.99 |
| Investment Properties |
1,568,342,712.21 |
| Fixed Assetes |
217,625,031.05 |
| Under-construction Projects |
318,528.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
167,186,671.69 |
| R&D expenses |
-- |
| Goodwill |
1,848,430,927.27 |
| Long-Term Deferred and Prepaid Expenses |
115,960,410.01 |
| Deferred Income Tax Assets |
73,374,934.12 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
4,960,552,401.83 |
| Total Assets |
15,434,704,311.40 |
| Short-Term Loans |
3,681,753,055.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
708,813,332.61 |
| Accounts Received In Advance |
86,587,262.98 |
| Employee Compensation Payable |
199,130,359.28 |
| Taxes Payable |
70,616,629.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
180,190,994.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,205,415,442.83 |
| Other Current Liabilities |
5,254,177.55 |
| Sub-Total of Current Liabilities |
6,308,387,869.20 |
| Long-term Loans |
963,935,586.99 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
174,041,269.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,208,798,696.55 |
| Total Liabilities |
7,517,186,565.75 |
| Paid-In Capital(Or Share Stock) |
1,045,909,322.00 |
| Capital Surplus |
656,108,885.69 |
| Surplus Reserve |
418,804,500.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,904,098,221.96 |
| Minority Stockholder's Interest |
815,726,131.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,101,791,614.45 |
| Owner's Equity（Stockholder's Equity） |
7,917,517,745.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,434,704,311.40 |
